IL‐17 plays a key role in the progression of rheumatoid arthritis in the TMJ, amplifying inflammation by stimulating the release of other pro‐inflammatory cytokines (such as TNF‐α, IL‐6, and IL‐1β), chemokines, and matrix metalloproteinases [18]. This evidence concerns the gene IL6 and rheumatoid arthritis.